This review highlights advancements in prevention and diagnosis of stomach cancer, indicating public health initiatives are essential.
Stomach cancer, or gastric cancer, remains one of the most fatal malignancies globally, with a significant burden in both incidence and mortality. Although its prevalence has declined in some developed regions due to better screening and reduced Helicobacter pylori infections, it continues to be a major health concern in low- and middle-income countries. This report provides an in-depth analysis of stomach cancer, focusing on its pathophysiology, risk factors, diagnostic advancements, treatment options, and preventive strategies. With particular emphasis on public health approaches and recent innovations in oncology, the report aims to bridge existing gaps in awareness, early diagnosis, and effective management. The integration of modern therapeutic technologies, public education, and healthcare policies are crucial to reducing the disease burden. The future of gastric cancer control lies in a combination of targeted therapies, early detection programs, and global collaboration.
No takes yet. Share an insight, caveat, or question.
Raj et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: